Milestones

Inflammation-Focused Device Maker Tivic Health Systems Sets Terms for $15 Million IPO

Tivic Health CEO Jennifer Ernst Wins Inc. Magazine’s Female Founder 100 Award

Tivic Health Receives Award for The Top 100 Healthcare Technology Companies of 2021

Jennifer Ernst, CEO and Co-Founder of Tivic Health Receives Award for Top 25 Women Leaders in Consumer HealthTech of 2021

FDA Expands Indication for Use of Tivic Health’s ClearUP Sinus Pain Relief to Include Congestion for Common Cold, Flu and Allergies

USPTO Grants Tivic’s First Four Patents

Fast Company 2020 World Changing Ideas Award Finalist in Health & Fitness; Honorable Mention in Consumer Products

ClearUP Receives CE Mark Approval

ClearUP named Editors’ Pick: CES 2020 Top Tech Digital Trends

Tivic Health named CES 2020 Innovation Awards Honoree

ClearUP Receives ISO 13485:2016 Certification

ClearUP named to TIME’s list of 100 Best Inventions of 2019

September product shipment

Finalist in MedTech Insight Awards: Most Innovative Team or Innovator of the Year

$8 million seed funding closed

FDA 510K Clearance

Top Pick at CES award from Techlicious

Best of CES award from Gear Diary

Runner-up for Best Clinical Manuscript at the ARS Annual Meeting for Stanford/Tivic paper


Received Best Gold Electrode Award for Most Promising Start-up from the Neurotech Leaders Forum

510(k) submission accepted by FDA, K-number issued

71 patient double-blind RCT completed at Stanford Sinus Center

Pivotal study completed for FDA submission, met agreed endpoint

Tivic Health files international patent applications

Double-blind, randomized, placebo-controlled study initiated at Stanford Sinus Center

Company Incorporated